|
1
|
Thomson S: Failed back surgery
syndrome-definition, epidemiology and demographics. Br J Pain.
7:56–59. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Thomson S and Jacques L: Demographic
characteristics of patients with severe neuropathic pain secondary
to failed back surgery syndrome. Pain Pract. 9:206–215. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Liu XG, Pang RP, Zhou LJ, Wei XH and Zang
Y: Neuropathic pain: Sensory nerve injury or motor nerve injury?
Adv Exp Med Biol. 904:59–75. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yalbuzdag SA, Erol AM, Sengul I, Celik C,
Solum S, Adilay HU and Gungor B: Temperament and character profile
in failed back surgery syndrome: A cross-sectional clinical study.
Turk Neurosurg. 26:912–917. 2016.PubMed/NCBI
|
|
5
|
Ellis A and Bennett DL: Neuroinflammation
and the generation of neuropathic pain. Br J Anaesth. 111:26–37.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yadav R and Weng HR: EZH2 regulates spinal
neuroinflammation in rats with neuropathic pain. Neuroscience.
349:106–117. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hauptman N and Glavac D: MicroRNAs and
long non-coding RNAs: Prospects in diagnostics and therapy of
cancer. Radiol Oncol. 47:311–318. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Morris KV and Mattick JS: The rise of
regulatory RNA. Nat Rev Genet. 15:423–437. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gu S, Xie R, Liu X, Shou J, Gu W and Che
X: Long coding RNA XIST contributes to neuronal apoptosis through
the downregulation of AKT phosphorylation and is negatively
regulated by miR-494 in rat spinal cord injury. Int J Mol Sci.
18:E7322017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li ZX, Zhu QN, Zhang HB, Hu Y, Wang G and
Zhu YS: MALAT1: A potential biomarker in cancer. Cancer Manag Res.
10:6757–6768. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sun Y and Ma L: New insights into long
non-coding RNA MALAT1 in cancer and metastasis. Cancers (Basel).
11:E2162019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mei H and Liu Y, Zhou Q, Hu K and Liu Y:
Long noncoding RNA MALAT1 acts as a potential biomarker in cancer
diagnosis and detection: A meta-analysis. Biomark Med. 13:45–54.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Xia C, Liang S, He Z, Zhu X, Chen R and
Chen J: Metformin, a first-line drug for type 2 diabetes mellitus,
disrupts the MALAT1/miR-142-3p sponge to decrease invasion and
migration in cervical cancer cells. Eur J Pharmacol. 830:59–67.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhang Y, Wu H, Wang F, Ye M, Zhu H and Bu
S: Long non-coding RNA MALAT1 expression in patients with
gestational diabetes mellitus. Int J Gynaecol Obstet. 140:164–169.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Qiao Y, Peng C, Li J, Wu D and Wang X:
LncRNA MALAT1 is neuroprotective in a rat model of spinal cord
ischemia-reperfusion injury through miR-204 regulation. Curr
Neurovasc Res. 15:211–219. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Xie X, Ma L, Xi K, Zhang W and Fan D:
MicroRNA-183 suppresses neuropathic pain and expression of AMPA
receptors by targeting mTOR/VEGF signaling pathway. Cell Physiol
Biochem. 41:181–192. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yang Z, Xu J, Zhu R and Liu L:
Down-regulation of miRNA-128 contributes to neuropathic pain
following spinal cord injury via activation of P38. Med Sci Monit.
23:405–411. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zheng Y, Zhu C, Ma L, Shao P, Qin C, Li P,
Cao Q, Ju X, Cheng G, Zhu Q, et al: miRNA-154-5p inhibits
proliferation, migration and invasion by targeting E2F5 in prostate
cancer cell lines. Urol Int. 98:102–110. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang X, Sun S, Tong X, Ma Q, Di H, Fu T,
Sun Z, Cai Y, Fan W, Wu Q, et al: MiRNA-154-5p inhibits cell
proliferation and metastasis by targeting PIWIL1 in glioblastoma.
Brain Res. 1676:69–76. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Damiano A, Zotta E, Goldstein J, Reisin I
and Ibarra C: Water channel proteins AQP3 and AQP9 are present in
syncytiotrophoblast of human term placenta. Placenta. 22:776–781.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Jelen S, Parm Ulhøi B, Larsen A, Frøkiær
J, Nielsen S and Rützler M: AQP9 expression in glioblastoma
multiforme tumors is limited to a small population of astrocytic
cells and CD15(+)/CalB(+) leukocytes. PLoS One. 8:e757642013.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lv Y, Huang Q, Dai W, Jie Y, Yu G, Fan X,
Wu A and Miao Q: AQP9 promotes astrocytoma cell invasion and
motility via the AKT pathway. Oncol Lett. 16:6059–6064.
2018.PubMed/NCBI
|
|
23
|
Huang D, Feng X, Liu Y, Deng Y, Chen H,
Chen D, Fang L, Cai Y, Liu H, Wang L, et al: AQP9-induced cell
cycle arrest is associated with RAS activation and improves
chemotherapy treatment efficacy in colorectal cancer. Cell Death
Dis. 8:e28942017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chung JM, Kim HK and Chung K: Segmental
spinal nerve ligation model of neuropathic pain. Methods Mol Med.
99:35–45. 2004.PubMed/NCBI
|
|
25
|
National Research Council (US) Committee
for the Update of the Guide for the Care and Use of Laboratory
Animals: Guide for the Care and Use of Laboratory Animals. National
Academies Press (US); Washington, DC: 2011
|
|
26
|
Breivik H: International Association for
the study of pain: Update on WHO-IASP activities. J Pain Symptom
Manage. 24:97–101. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Beltramo M, Bernardini N, Bertorelli R,
Campanella M, Nicolussi E, Fredduzzi S and Reggiani A: CB2
receptor-mediated antihyperalgesia: Possible direct involvement of
neural mechanisms. Eur J Neurosci. 23:1530–1538. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Li JH, Liu S, Zhou H, Qu LH and Yang JH:
StarBase v2.0: Decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA
interaction networks from large-scale CLIP-Seq data. Nucleic Acids
Res. 42:D92–D97. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Torrance N, Smith BH, Watson MC and
Bennett MI: Medication and treatment use in primary care patients
with chronic pain of predominantly neuropathic origin. Fam Pract.
24:481–485. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Torrance N, Smith BH, Bennett MI and Lee
A: The epidemiology of chronic pain of predominantly neuropathic
origin. Results from a general population survey. J Pain.
7:281–289. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Qiao W, Cao N and Yang L: MicroRNA-154
inhibits the growth and metastasis of gastric cancer cells by
directly targeting MTDH. Oncol Lett. 14:3268–3274. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Xin C, Zhang H and Liu Z: miR-154
suppresses colorectal cancer cell growth and motility by targeting
TLR2J. Mol Cell Biochem. 387:271–277. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Pang X, Huang K, Zhang Q, Zhang Y and Niu
J: miR-154 targeting ZEB2 in hepatocellular carcinoma functions as
a potential tumor suppressor. Oncol Rep. 34:3272–3279. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Halsey AM, Conner AC, Bill RM, Logan A and
Ahmed Z: Aquaporins and their regulation after spinal cord injury.
Cells. 7:E1742018. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Nesic O, Lee J, Unabia GC, Johnson K, Ye
Z, Vergara L, Hulsebosch CE and Perez-Polo JR: Aquaporin 1-a novel
player in spinal cord injury. J Neurochem. 105:628–640. 2008.
View Article : Google Scholar : PubMed/NCBI
|
